Client News

Verona Pharma plc: Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM

MagForce AG Publishes Shareholder Letter

Adocia announces a Video Conference to Present a Corporate Update Wednesday, September 23rd, 2020

InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer

Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease

Adocia announces Positive Topline Results of Phase 1b Study for M1Pram in People with type 1 Diabetes

Newron announces half-year 2020 results

Adrenomed AG: Data from Adrenomed’s AdrenOSS-2 trial with Adrecizumab in Septic Shock to be presented during e-ISICEM

4basebio AG comments on the takeover bid of Sparta AG

InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia